Analyst Research Report Snapshot

Title:

IMMUNODIAGNOSTIC SYSTEM HOLDINGS - HIGHLY RATED BET

Price:

$10.00

Provider:

Edison Investment Research

Date:

14 Jul 2010

Pages:

2

Type:

AcrobatPDF

Companies referenced:

IDH.L

Available for Immediate Download
Summary:

Strong growth continues with organic sales increasing by £10.9m (up 43%) giving £37.16m overall (including £1.3m currency). FDA approval of iSYS on 29 June now enables direct targeting of automated system competitors in the key US market. Diasorin is the main US competitor. The share price reflects the excellent growth prospects, but the price is running ahead of the company’s realistic ability to deliver to City timings. The 2010 P/E without R&D capitalisation would be 62x.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.